NCT07238101

Brief Summary

Researchers will compare dexmedetomidine to fentanyl to see which drug provides better hemodynamic stability during spinal surgery. Participants will :

  • Receive either dexmedetomidine or fentanyl as part of their anesthesia during elective surgery
  • Have their mean arterial pressure and heart rate measured at several time points during the procedure
  • Be monitored throughout surgery to assess intraoperative hemodynamic responses and stability

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started May 2024

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 8, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 23, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 20, 2025

Completed
Last Updated

November 20, 2025

Status Verified

September 1, 2025

Enrollment Period

5 months

First QC Date

September 23, 2025

Last Update Submit

November 14, 2025

Conditions

Keywords

DexmedetomidineFentanylHemodynamicsAnesthesiaRandomized Controlled TrialAdam Malik Hospital

Outcome Measures

Primary Outcomes (1)

  • Change in Mean Arterial Pressure (MAP) during spinal surgery

    Measurement of mean arterial pressure (MAP) at multiple time points to compare the effects of dexmedetomidine versus fentanyl on intraoperative hemodynamic stability during spinal surgery.

    MAP will be recorded at baseline (T0), and at 5, 10, 15, 20, 25, 30, 60, 120, 180, and 240 minutes after drug administration

Secondary Outcomes (1)

  • Change in Heart Rate (Pulse) during spinal surgery

    Heart rate will be recorded at the same time points as MAP: baseline (T0), and at 5, 10, 15, 20, 25, 30, 60, 120, 180, and 240 minutes after drug administration

Study Arms (2)

Dexmedetomidine Group

EXPERIMENTAL

Participants in this group received dexmedetomidine at a dose of 0.5 μg/kgBW/hour intravenously as part of anesthesia management for spinal surgery. The purpose is to evaluate the effect of dexmedetomidine on hemodynamic stability, including heart rate and mean arterial pressure, during and after induction of anesthesia.

Drug: Dexmedetomidine

Fentanyl Group

EXPERIMENTAL

Participants in this group received fentanyl at a dose of 1.5 μg/kgBW/hour intravenously as part of anesthesia management for spinal surgery. This arm serves as the comparison group to evaluate differences in hemodynamic parameters such as heart rate and mean arterial pressure compared to dexmedetomidine.

Drug: fentanyl

Interventions

Intravenous administration of dexmedetomidine at a dose of 0.5 μg/kgBW/hour during spinal surgery. Dexmedetomidine is a highly selective alpha-2 adrenergic agonist with sedative and analgesic properties. The aim is to evaluate its effect on maintaining hemodynamic stability, including mean arterial pressure (MAP) and heart rate, during and after anesthesia induction.

Dexmedetomidine Group

Intravenous administration of fentanyl at a dose of 1.5 μg/kgBW/hour during spinal surgery. Fentanyl is a potent synthetic opioid analgesic used to manage pain and modulate hemodynamic responses during surgery. This group serves as the comparator to evaluate differences in hemodynamic parameters, particularly MAP and heart rate, compared to dexmedetomidine.

Fentanyl Group

Eligibility Criteria

Age17 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients aged between 17 and 60 years old
  • Classified as ASA physical status 1-3
  • Scheduled for elective spinal surgery
  • Provided written informed consent

You may not qualify if:

  • History of drug hipersensitivity to fentanyl or dexmetomidine
  • Presence of Cardiac Anatomical abnormalities
  • Vsacular disorders or other conditions that may interfere with the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Universitas Sumatera Utara

Medan, North Sumatra, 20222, Indonesia

Location

Related Publications (13)

  • Gilpin B. Changing the public health landscape through advocacy. Circulation. 1997 Apr 15;95(8):1978. doi: 10.1161/01.cir.95.8.1978. No abstract available.

  • Hasmi. Epidemiological research methods. Jakarta: CV Trans Info Media; 2016.

    RESULT
  • Rizkiya P, Margarita N, Harijono B, Herawati L. Analysis of dexmedetomidine addition in elective major spinal surgery in RSUD Dr. Soetomo. Maj Anestesiol Indones. 2020;9(2):1-9.

    RESULT
  • Yun SH, Song SW, Park JC. Beneficial effects of the addition of intrathecal fentanyl to bupivacaine for spinal anesthesia in cesarean section. Anesth Pain Med (Seoul). 2017;12(3):233-239. doi:10.17085/apm.2017.12.3.233.

    RESULT
  • Park SJ, Shin S, Kim SH, Kim HW, Kim SH, Do HY, Choi YS. Comparison of Dexmedetomidine and Fentanyl as an Adjuvant to Ropivacaine for Postoperative Epidural Analgesia in Pediatric Orthopedic Surgery. Yonsei Med J. 2017 May;58(3):650-657. doi: 10.3349/ymj.2017.58.3.650.

  • Choi JW, Joo JD, Kim DW, In JH, Kwon SY, Seo K, Han D, Cheon GY, Jung HS. Comparison of an Intraoperative Infusion of Dexmedetomidine, Fentanyl, and Remifentanil on Perioperative Hemodynamics, Sedation Quality, and Postoperative Pain Control. J Korean Med Sci. 2016 Sep;31(9):1485-90. doi: 10.3346/jkms.2016.31.9.1485.

  • Kaye AD, Chernobylsky DJ, Thakur P, Siddaiah H, Kaye RJ, Eng LK, Harbell MW, Lajaunie J, Cornett EM. Dexmedetomidine in Enhanced Recovery After Surgery (ERAS) Protocols for Postoperative Pain. Curr Pain Headache Rep. 2020 Apr 2;24(5):21. doi: 10.1007/s11916-020-00853-z.

  • Khosravi F, Sharifi M, Jarineshin H. Comparative Study of Fentanyl vs Dexmedetomidine as Adjuvants to Intrathecal Bupivacaine in Cesarean Section: A Randomized, Double-Blind Clinical Trial. J Pain Res. 2020 Oct 7;13:2475-2482. doi: 10.2147/JPR.S265161. eCollection 2020.

  • Sahraei R, Ghaedi M, Haghbeen M, Sadegh M, Jahromi S. Comparison of ketamine and dexmedetomidine in reducing complications after laparoscopic cholecystectomy surgery. Med J Islam Repub Iran. 2023;12(2).

    RESULT
  • Emam MWM, Hassan BEDE, Abd El-Hamid HM, Ibrahim IA, Saleh MAE. Comparative study between dexmedetomidine and fentanyl as adjuvants to bupivacaine for postoperative epidural analgesia in abdominal surgery: a randomized controlled trial. Egypt J Anaesth. 2023;39(1):635-641. doi:10.1080/11101849.2023.2238520

    RESULT
  • Sigdel R, Lama M, Gurung S, et al. Intrathecal bupivacaine with fentanyl versus bupivacaine alone in cases undergoing elective cesarean section: comparison of hemodynamics. J Nepal Health Res Counc. 2023;21(2).

    RESULT
  • Hassanin AAM, Ali NS, Elhiny MMMA. Effect of dexmedetomidine versus fentanyl on recovery responses to tracheal extubation in vitrectomy: randomized controlled trial. Egypt J Anaesth. 2023;39(1):40-49. doi:10.1080/11101849.2023.2166617.

    RESULT
  • Ma RX, Qiao RQ, Xu MY, Li RF, Hu YC. Application of Controlled Hypotension During Surgery for Spinal Metastasis. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221105718. doi: 10.1177/15330338221105718.

MeSH Terms

Interventions

DexmedetomidineFentanyl

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPiperidines

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
dr

Study Record Dates

First Submitted

September 23, 2025

First Posted

November 20, 2025

Study Start

May 8, 2024

Primary Completion

September 20, 2024

Study Completion

March 20, 2025

Last Updated

November 20, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations